18 No source found (not proven false)
The hospitalization rate for influenza in young people is approximately 0.01%, compared to about 0.2% for pre-Delta COVID-19, representing an almost 20-fold higher hospitalization risk.
"the hospitalization rate for the flu virus in young people is about 0.01%. If you look at the pre-Delta COVID-19 data, it's about 0.2%, so it's almost 20-fold higher for COVID-19 in the young than it is for the flu." (said at 0:02:34)
No published record matching the claim that the hospitalization rate for influenza in young people is approximately 0.01% compared to about 0.2% for pre-Delta COVID-19 was located; this does not prove the claim false.
A preprint analysis of US electronic health records concluded that young males infected with SARS-CoV-2 were up to six times more likely to develop myocarditis than those who received a COVID-19 vaccine.
"this preprint, non-peer-reviewed article using electronic records in the United States also agreed with the Israeli data that was published in the New England Journal of Medicine and came to the conclusion that young males infected with the virus are up to six times more likely to develop myocarditis as those who received the vaccine." (said at 0:07:57)
No published record matching the claim that a US electronic health record preprint analysis found young males infected with SARS-CoV-2 were up to six times more likely to develop myocarditis than those who received a COVID-19 vaccine was located; this does not prove the claim false.
Studies from Israel and the US found that a high percentage of patients under 50 presenting to the emergency room with strokes had active or prior SARS-CoV-2 infections that they were previously unaware of.
"there was this study, multiple studies, one out of Israel and a couple out of the United States, showing that people under the age of 50 were coming into the emergency room for strokes. And one of the studies out of Israel found, because they test everyone for COVID-19, you know, a great deal of the like a high percentage of the people that were coming in for these strokes, these young people under 50, had COVID-19 and didn't even know they had had it." (said at 0:15:06)
No published record matching the claim—that studies from Israel and the United States demonstrated a high percentage of patients under age 50 presenting to the emergency department with strokes had previously unrecognized SARS-CoV-2 infections—was located; this does not prove the claim false.
Over 5% of death certificates involving COVID-19 in CDC data listed COVID-19 as the only cause of death mentioned.
"the number of deaths that mention one or more of the conditions indicated is shown for all deaths involving COVID-19, and by age groups for over 5% of these deaths COVID-19 was the only cause mentioned on the death certificate." (said at 0:18:00)
No published record matching the claim that CDC death certificate data showed over 5% of COVID-19-related deaths listed COVID-19 as the only cause of death mentioned was located; this does not prove the claim false.
The United States has fewer than one million acute care hospital beds.
"We only have under a million acute care beds in the United States, and so as a result of that, you are going to quickly overwhelm the healthcare system." (said at 0:04:32)
No published record matching the claim that the United States has fewer than one million acute care hospital beds was located; this does not prove the claim false.
The SARS-CoV-2 spike protein produced by mRNA vaccines has a transmembrane domain that anchors it into the cell's plasma membrane rather than allowing it to circulate freely.
"And the spike protein itself has a region on it called a transmembrane domain that sticks it—it—it's like an anchor. It anchors into that plasma membrane, so it is not freely floating out into your circulation. It is stuck there." (said at 0:30:17)
No published record matching the claim that the SARS-CoV-2 spike protein produced by mRNA vaccines contains a transmembrane domain anchoring it into the plasma membrane rather than circulating freely was located; this does not prove the claim false.
In a Pfizer biodistribution study, rats received 50 micrograms of the Pfizer-BioNTech vaccine, compared to a 30-microgram human dose.
"So humans are given 30 micrograms of the Pfizer-BioNTech vaccine for one dose; the rat was given 50 micrograms of the Pfizer-BioNTech vaccine." (said at 0:30:47)
No peer-reviewed scientific publication indexed in PubMed matching the specific experimental dosing details of the Pfizer preclinical rodent biodistribution study versus human clinical dosing was located; this does not prove the claim false. Preclinical biodistribution and pharmacokinetic evaluations of lipid nanoparticle formulations (such as those submitted in regulatory assessment dossiers to the EMA and PMDA) are typically documented in regulatory assessment reports rather than indexed primary journal publications.
In a Pfizer animal study where mice were administered 2 micrograms of the mRNA vaccine, the radiolabeled tag was only detected in the liver and was completely cleared after 48 hours.
"In this case, they gave mice 2 micrograms of the mRNA vaccine, and that vaccine did not go to all these other organs. In fact, the only organ that was shown to have any amount of—of the mRNA, of this radiolabeled tag, was the liver, and it was completely gone after 48 hours." (said at 0:32:18)
No published record matching the claim that a 2-microgram dose of radiolabeled mRNA vaccine administered to mice localized exclusively to the liver and completely cleared within 48 hours was located; this does not prove the claim false.
Approximately 20,000 people aged 40 to 49 died from COVID-19 in the United States as reported by the CDC as of mid-2021.
"People aged 40 to 49, about 20,000 people have died from COVID-19 according to the CDC website." (said at 0:51:19)
No published record matching the claim that approximately 20,000 people aged 40 to 49 died from COVID-19 in the United States as reported by the CDC as of mid-2021 was located; this does not prove the claim false.
Approximately 10,000 people aged 18 to 39 died from COVID-19 in the United States as of mid-2021.
"18 to 39-year-olds, about 10,000 people have died from COVID-19 in that age range." (said at 0:51:45)
No published record matching the claim that approximately 10,000 people aged 18 to 39 died from COVID-19 in the United States as of mid-2021 was located; this does not prove the claim false.
In Israel during the Delta variant surge in July and August 2021, unvaccinated individuals accounted for the highest rate of severe COVID-19 cases across all age strata compared to fully vaccinated individuals.
"And you can see here that over the months of July and August, which were just pure Delta at the time, it was the unvaccinated that were having the most severe cases... If you break it down in the next graph by age, you'll see that the same relationship occurs with age, but again in each of these age categories, if you age-stratify them, you will see that it is the unvaccinated that are leading the severe cases." (said at 1:08:20)
No published record matching the claim that unvaccinated individuals in Israel accounted for the highest rate of severe COVID-19 cases across all age strata during July and August 2021 was located; this does not prove the claim false.
Human dosing of ivermectin yields a maximum free plasma concentration of approximately 0.28 micromolar, which is about 250 times lower than the in vitro concentration required to inhibit SARS-CoV-2.
"The problem was is that when you look at the actual dosing of ivermectin in a human being, you only get about 0.28 micromolar... And so this paper here that was published in the British Journal of Clinical Pharmacology said that the free plasma concentration of ivermectin was actually 250 times lower than the concentration required to reduce viral replication of SARS-CoV-2 in vitro." (said at 1:23:09)
No published record matching the claim regarding human dosing of ivermectin yielding a free plasma concentration of approximately 0.28 micromolar (or 250 times lower than the in vitro concentration required to inhibit SARS-CoV-2) was located; this does not prove the claim false.
In regions such as Egypt, the Middle East, and South America, the prevalence of clinically silent parasitic infections in the population reaches 50% to 60% in some studies.
"And if you look at some of the data in, for instance, in Egypt and in um in the Middle East, South America, the amount of clinically silent parasitic infections in the population approaches, in some studies, 50 to 60%." (said at 1:25:24)
No published record matching the claim that the prevalence of clinically silent parasitic infections reaches 50% to 60% in specific populations of Egypt, the Middle East, or South America was located; this does not prove the claim false.
COVID-19 vaccines authorized in the United States incorporate a stabilized pre-fusion spike protein conformation, preventing the induction of post-fusion antibodies.
"what the brilliant work of Jason McLellan showed is that you could basically lock a viral protein into the pre-fusion complex. And when you then use that pre-fusion viral protein in a vaccine, you don't make post-fusion antibodies because your body isn't exposed to that structure of the viral protein. And so that's what we have in all of our US vaccines: the pre-fusion viral protein, the pre-fusion spike protein." (said at 1:04:54)
No published record matching the claim that US-authorized COVID-19 vaccines prevent the induction of post-fusion antibodies by locking the spike protein into a pre-fusion conformation was located; this does not prove the claim false.
The UK REACT study found that in random cross-sectional population samplings, vaccinated individuals with breakthrough infections had lower viral loads on average than unvaccinated infected individuals.
"And that's exactly what this real-time data that's being aggregated out of the UK, it's called the REACT study, that study found that if you would take a random sampling of people at any point in time, vaccinated breakthrough cases, they had a lower viral load than unvaccinated." (said at 1:48:10)
No published record matching the claim that the UK REACT study found lower viral loads on average among vaccinated individuals with breakthrough infections compared to unvaccinated infected individuals was located; this does not prove the claim false.
A preprint study from the Netherlands showed that at any given viral load, viral particles shed by vaccinated healthcare workers were less likely to culture viable virus compared to those shed by unvaccinated individuals.
"I was able to find a preprint of an article that just came out a couple of weeks ago that looked at the quality of those viral particles that are shed from those that have breakthrough infections... You can clearly see here that at any given viral load, the vaccinated healthcare worker in this study from the Netherlands was shown to have a less likelihood of infecting somebody based on viral culture." (said at 1:52:40)
No published record matching the claim that a study from the Netherlands demonstrated vaccinated healthcare workers shed viral particles less likely to yield viable virus in culture at any given viral load compared to unvaccinated individuals was located; this does not prove the claim false.
Most major SARS-CoV-2 variants, including Alpha, Beta, Gamma, and Delta, emerged from populations with low vaccination rates rather than highly vaccinated populations.
"So if you look at the examples that we have, whether it's Alpha, Beta, Gamma, Delta, most of these variants, if not all of them, came from populations that were not vaccinated." (said at 2:04:24)
No published record matching the claim that major SARS-CoV-2 variants (Alpha, Beta, Gamma, and Delta) emerged from populations with low vaccination rates rather than vaccinated populations was located; this does not prove the claim false.
In the United Kingdom's third COVID-19 wave (Delta wave), death rates were decoupled from rising case counts compared to the second pre-vaccine wave.
"In the second wave, which is in red, the left half of that shows how quickly the infections rose as time went on, and concomitantly on the other side of it, on the right side, you can see how quickly deaths unfortunately also rose in that second wave, and that's without the vaccines that we currently have now. And then the third wave came, which was the Delta wave, and what you can see there, which is a stark departure from the wave on the left, is that while you have the increasing amount of infections, which are basically positive PCRs as we've talked about, what's missing there from that is the increased amount of deaths in that third wave, and that is with the vaccine." (said at 2:19:59)
No published record matching the claim regarding the decoupling of case counts and death rates between the second and third (Delta) COVID-19 waves in the United Kingdom was located; this does not prove the claim false.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.